[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
The Indian Investor @Anvith_ on x 19.5K followers
Created: 2025-07-23 14:34:34 UTC
🧬 Senores Pharma : Blockbuster Q1FY26 🔥
▪️ PAT ⬆️ XX% at ₹21 Cr (YoY)
▪️ Revenue ⬆️ XX% at ₹138 Cr (YoY)
▪️ EBIDTA ⬆️ XX% at ₹34 Cr (YoY)
▪️ Regulated Markets Revenue ⬆️ XX% at ₹90 Cr (YoY) | EBITDA Margin: 35.5%.
▪️ Emerging Markets Revenue ⬆️ XX% at ₹29 Cr (YoY) | EBITDA Margin: 6%.
▪️Launched X own ANDA products
▪️ Received approval for X in Regulated Markets.
▪️ Regulated Markets: XX Own commercial products, XX Approved ANDA, XX Pipeline.
▪️ Emerging Markets: XXX Registered products, XXX under Registration in 40+ countries.
▪️ CDMO/CMO segment scaling up with new contracts & increased customer share.
▪️ Positive Operating Cash Flow: ₹11 Cr in Q1 FY26.
▪️ X formulation facilities (US & India), X API facilities (India), strong R&D.
▪️ Targeting pan-India Branded Generics leadership by FY26 end.
#Senores #SenoresPharma #Q1FY26 #CDMO
XXXXXX engagements
Related Topics investment